Presentation description

This study examines the mental health of adolescents with cystic fibrosis (CF) on Elexacaftor/Tezacaftor/Ivacaftor (ETI) using the GAD-7 and PHQ-9. Other factors such as BMI percentile, lung capacity, age, race, sex, and gender were all taken into account.